about
Facioscapulohumeral dystrophy: incomplete suppression of a retrotransposed geneThe H19 lincRNA is a developmental reservoir of miR-675 that suppresses growth and Igf1rThe Wnt3a/β-catenin target gene Mesogenin1 controls the segmentation clock by activating a Notch signalling programAcceleration of mesoderm development and expansion of hematopoietic progenitors in differentiating ES cells by the mouse Mix-like homeodomain transcription factorOVOL2 is a critical regulator of ER71/ETV2 in generating FLK1+, hematopoietic, and endothelial cells from embryonic stem cells.Inducible Gata1 suppression expands megakaryocyte-erythroid progenitors from embryonic stem cells.Biphasic myopathic phenotype of mouse DUX, an ORF within conserved FSHD-related repeats.A PPARγ transcriptional cascade directs adipose progenitor cell-niche interaction and niche expansion.Expansion and Purification Are Critical for the Therapeutic Application of Pluripotent Stem Cell-Derived Myogenic Progenitors.Cooperative interaction of Etv2 and Gata2 regulates the development of endothelial and hematopoietic lineagesDecreased proliferation kinetics of mouse myoblasts overexpressing FRG1.Direct induction of haematoendothelial programs in human pluripotent stem cells by transcriptional regulators.Transcripts that associate with the RNA binding protein, DEAD-END (DND1), in embryonic stem (ES) cellsp53 regulates cell cycle and microRNAs to promote differentiation of human embryonic stem cells.Dominant lethal pathologies in male mice engineered to contain an X-linked DUX4 transgeneAcquisition of a quantitative, stoichiometrically conserved ratiometric marker of maturation status in stem cell-derived cardiac myocytes.The plasminogen activation system modulates differently adipogenesis and myogenesis of embryonic stem cells.Gene therapy by allele selection in a mouse model of beta-thalassemia.Hematopoietic differentiation of induced pluripotent stem cells from patients with mucopolysaccharidosis type I (Hurler syndrome)Enhanced hematopoietic differentiation of embryonic stem cells conditionally expressing Stat5.Derivation and high engraftment of patient-specific cardiomyocyte sheet using induced pluripotent stem cells generated from adult cardiac fibroblast.Modulation of TGF-β signaling by endoglin in murine hemangioblast development and primitive hematopoiesis.Prospective isolation of skeletal muscle stem cells with a Pax7 reporterER71 directs mesodermal fate decisions during embryogenesisHematopoiesis from embryonic stem cells: lessons from and for ontogeny.Drosophila Cyclin G and epigenetic maintenance of gene expression during developmentProteomic analysis of Sox2-associated proteins during early stages of mouse embryonic stem cell differentiation identifies Sox21 as a novel regulator of stem cell fate.Zinc finger protein ZFP57 requires its co-factor to recruit DNA methyltransferases and maintains DNA methylation imprint in embryonic stem cells via its transcriptional repression domainFunctional myogenic engraftment from mouse iPS cells.Nuclear transplantation, embryonic stem cells and the potential for cell therapy.Genome-wide analysis of target genes regulated by HoxB4 in hematopoietic stem and progenitor cells developing from embryonic stem cells.Assessment of the myogenic stem cell compartment following transplantation of Pax3/Pax7-induced embryonic stem cell-derived progenitors.Human ES- and iPS-derived myogenic progenitors restore DYSTROPHIN and improve contractility upon transplantation in dystrophic mice.High Frequency Hearing Loss and Hyperactivity in DUX4 Transgenic Mice.A critical role for endoglin in the emergence of blood during embryonic development.Transcriptional Inhibitors Identified in a 160,000-Compound Small-Molecule DUX4 Viability Screen.Cellular Aging Contributes to Failure of Cold-Induced Beige Adipocyte Formation in Old Mice and Humans.DNA-binding sequence specificity of DUX4.Lineage Reprogramming of Fibroblasts into Proliferative Induced Cardiac Progenitor Cells by Defined FactorsCaspase activity mediates the differentiation of embryonic stem cells.
P50
Q21563391-0B5D67CE-240D-449E-BC1F-F6491879F88BQ24633774-B5277175-1362-44B5-BEF9-3C90C1DC9743Q28511944-84D3BA8C-867F-4A6F-8959-0986DE880EB3Q28594667-BC4AFF25-D769-4DAE-AC07-C108739E4595Q30366308-27A5C4C8-D223-4F09-944B-8BDA1A7F9EF1Q30657328-D15071C6-771C-48A5-970C-30F76EE81B7DQ33503626-1B0D0CC6-F217-4ADA-AA42-A31A7C1DF41EQ33851239-993E2BA1-C6D7-4C6B-A93C-928EF94CEF4AQ33905388-3BDF5115-3998-405E-94D4-1F7E50C5E990Q33906266-7C92FAE4-93FF-43C6-B21E-28A2954B698BQ33908480-B95A570D-9309-46EB-AAA9-002BD2A5A26DQ33935685-41DCF0E4-3617-4489-97D0-B534133AD996Q33996172-C3B6B6A9-AC8E-428C-A7E8-EE78A27245F1Q34184384-9783D52A-D0DE-4FCE-A152-E1E59C26E85EQ34300873-4A11AA07-0029-403D-B26B-B9ECB193DFB3Q34469539-9AFB6636-F4E9-4009-9F1B-F5FF8AC226FBQ34473975-CEAEBF83-CD41-456F-88F5-CA851CF27B29Q34519981-59D81936-3DF2-473A-9C6B-522606CEF926Q34557967-F5733C1D-CD55-4A75-A158-08D66E2F7FACQ34582516-BE94AB1D-90D6-4702-908A-541A81D01328Q35002134-4F217CB7-E54B-4448-9751-D17E79729896Q35114532-8377C349-8850-48B1-BCD3-5F354C3E9318Q35213447-CE0B2E82-2C42-451F-A510-F81F872D0C0BQ35306113-E64C9C1F-6794-4767-BD4B-A8C11A0F865EQ35571377-2478E11B-B93A-486A-9298-E1692435D664Q35627101-1FC4D709-B417-46C9-AC85-871388FA4192Q35677096-BAA792A6-983E-466C-BA00-9B28BB61CA51Q35694053-6EEE40ED-1E24-4CB9-8D30-F69E16EC1AECQ35735727-86874C0D-B5C5-4AB3-9A52-3B5B6D663614Q35800727-8B514ABF-F275-42EE-84ED-EDB3216CF3C6Q35812097-BFA057C3-5FEC-4F63-9086-946706E86E27Q35886706-A8404E95-DE14-4936-B727-8F23018FD6FBQ35947481-847BB609-6E8A-4F88-94A8-0CF763449061Q35957673-A14ED02B-E847-4462-8F23-2AAE93000146Q36015189-585FC383-925D-40E8-AF2A-3EDA3D0CA6BDQ36035011-51A850A6-FEB0-4AF7-9B4C-A8EB7280052BQ36204662-44A69188-0B97-4DF3-B634-158C8F7499BBQ36513553-D4F0B559-92E0-4FCD-908F-6F98E9103034Q36654906-946BAC97-40FD-4455-8B83-3224B580B830Q36807303-38C1A306-1C0D-4280-B934-A918D61C7906
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Michael Kyba
@ast
Michael Kyba
@en
Michael Kyba
@es
Michael Kyba
@sl
type
label
Michael Kyba
@ast
Michael Kyba
@en
Michael Kyba
@es
Michael Kyba
@sl
prefLabel
Michael Kyba
@ast
Michael Kyba
@en
Michael Kyba
@es
Michael Kyba
@sl
P106
P1153
6602498710
P21
P31
P496
0000-0002-5579-7534